Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Health-Related Stocks Put Downward Pressure on the Dow

Last week the markets sprinted higher, and the Dow Jones Industrial Average (DJINDICES: ^DJI  ) climbed 261, briefly rising above the 15,000 mark. The S&P 500 also had a fantastic week, gaining 32 points, or 2.03%, to surpass 1,600. But after the bull run of the past five trading sessions, investors are taking it easy today. As of 12:45 p.m. EDT the Dow is flat, while the S&P 500 is up just 0.2%. The Nasdaq, which gained more than 3% last week, is once again the best performer today, up 0.4%.

Dow losers
(NYSE: MRK  ) is again trading lower today, down 1%. Merck ended last week as the worst-performing Dow component after it dropped 4.56%. Today's decline is simply in keeping with the recent slide after the company announced poor quarterly earnings and cut its forecast 2013 earnings by $0.15. Analysts have not begun bashing the company with downgrades, which may likely begin soon, but investors have certainly voiced their displeasure with the company by dramatically lowering the share price over just a few trading sessions.

Shares of Pfizer (NYSE: PFE  ) are down by 0.6% this afternoon despite the announcement that the company will soon begin selling its erectile-dysfunction medication online. Customers will still be required to have a prescription, but this may make it easier for individuals to get their medication regularly. This move has also raised concerns among other companies within the industry, because it will likely disturb the current distribution model. 

And to round out the health care industry losers today, shares of Johnson & Johnson (NYSE: JNJ  ) are down more than 1%. As with Merck, there is little news pertaining to the company today, but some have speculated that the high price-to-earnings ratio and recent run-up in share price are making some investors reconsider whether the stock has any more gas in the tank. Year to date, shares are up 21.1%, and for a company most consider to be a more stable, slow-growing organization, that price appreciation over such a short time frame is a little excessive. Today's pullback is likely just investors taking money off the table.

Is bigger really better?
Involved in everything from baby powder to biotech, Johnson & Johnson is criticized as being spread way too thin. If you want to know if J&J is a bloated corporate whale or a well-diversified giant that's perfect for your portfolio, check out the Fool's new premium report outlining the Johnson & Johnson story in terms that any investor can understand. Claim your copy by clicking here now.

Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2411253, ~/Articles/ArticleHandler.aspx, 10/1/2016 1:28:25 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 16 hours ago Sponsored by:
DOW 18,308.15 164.70 0.91%
S&P 500 2,168.27 17.14 0.80%
NASD 5,312.00 42.85 0.81%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 5:01 PM
^DJI $18308.15 Up +164.70 +0.91%
JNJ $118.13 Up +0.86 +0.73%
Johnson and Johnso… CAPS Rating: *****
MRK $62.41 Up +0.50 +0.81%
Merck and Co. CAPS Rating: ****
PFE $33.87 Up +0.55 +1.65%
Pfizer CAPS Rating: ****